Urothelial Cancer
Showing NaN - NaN of 6
Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)
Recruiting
- Urothelial Cancer
- Nivolumab
- +4 more
-
Birmingham, Alabama
- +196 more
Jan 17, 2023
Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),
Active, not recruiting
- Carcinoma, Transitional Cell
- +6 more
- enfortumab vedotin (EV)
- +4 more
-
Anchorage, Alaska
- +105 more
Dec 19, 2022
Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
Completed
- Urothelial Cancer
-
Chicago, IllinoisUniversity of Chicago
May 1, 2018
Urothelial Cancer Trial in United States (Gemcitabine, Cisplatin, Sunitinib)
Completed
- Urothelial Cancer
- Gemcitabine, Cisplatin, Sunitinib
-
Tucson, Arizona
- +47 more
Sep 15, 2016